• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炭疽芽胞杆菌表面蛋白 EA1 对小鼠炭疽的保护作用。

Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.

机构信息

Laboratory of Food Microbiology and Immunology, Research Center for Animal Hygiene and Food Safety, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido 080-8555, Japan.

出版信息

Biochem Biophys Res Commun. 2012 May 4;421(2):323-8. doi: 10.1016/j.bbrc.2012.04.007. Epub 2012 Apr 9.

DOI:10.1016/j.bbrc.2012.04.007
PMID:22507985
Abstract

Bacillus anthracis spores germinate to vegetative forms in host cells, and produced fatal toxins. A toxin-targeting prophylaxis blocks the effect of toxin, but may allow to grow vegetative cells which create subsequent toxemia. In this study, we examined protective effect of extractable antigen 1 (EA1), a major S-layer component of B. anthracis, against anthrax. Mice were intranasally immunized with recombinant EA1, followed by a lethal challenge of B. anthracis spores. Mucosal immunization with EA1 resulted in a significant level of anti-EA1 antibodies in feces, saliva and serum. It also delayed the onset of anthrax and remarkably decreased the mortality rate. In addition, the combination of EA1 and protective antigen (PA) protected all immunized mice from a lethal challenge with B. anthracis spores. The numbers of bacteria in tissues of EA1-immunized mice were significantly decreased compared to those in the control and PA alone-immunized mice. Immunity to EA1 might contribute to protection at the early phase of infection, i.e., before massive multiplication and toxin production by vegetative cells. These results suggest that EA1 is a novel candidate for anthrax vaccine and provides a more effective protection when used in combination with PA.

摘要

炭疽杆菌孢子在宿主细胞中发芽为营养体形式,并产生致命毒素。毒素靶向预防措施可以阻止毒素的作用,但可能会允许营养体细胞生长,从而导致随后的毒血症。在这项研究中,我们研究了提取抗原 1(EA1)对炭疽病的保护作用。EA1 是炭疽杆菌的主要 S 层成分之一。用重组 EA1 通过鼻腔免疫小鼠,然后用炭疽杆菌孢子进行致命挑战。EA1 的黏膜免疫导致粪便、唾液和血清中抗 EA1 抗体的水平显著升高。它还延迟了炭疽病的发病,并显著降低了死亡率。此外,EA1 和保护性抗原(PA)的组合可保护所有用炭疽杆菌孢子进行致命挑战的免疫小鼠。与对照组和仅用 PA 免疫的小鼠相比,EA1 免疫小鼠组织中的细菌数量明显减少。对 EA1 的免疫可能有助于在感染的早期阶段(即在营养体大量繁殖和产生毒素之前)提供保护。这些结果表明,EA1 是炭疽疫苗的一种新型候选物,与 PA 联合使用时提供更有效的保护。

相似文献

1
Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice.炭疽芽胞杆菌表面蛋白 EA1 对小鼠炭疽的保护作用。
Biochem Biophys Res Commun. 2012 May 4;421(2):323-8. doi: 10.1016/j.bbrc.2012.04.007. Epub 2012 Apr 9.
2
An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.一种同时针对炭疽杆菌毒素和细菌的鼻内疫苗可使兔子抵御气溶胶孢子攻击。
Vaccine. 2006 May 1;24(18):3953-63. doi: 10.1016/j.vaccine.2006.02.024. Epub 2006 Feb 28.
3
Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.聚γ-d-谷氨酸与保护性抗原结合疫苗可在豚鼠和兔子体内诱导产生针对炭疽芽孢杆菌保护性抗原和荚膜的功能性抗体。
FEMS Immunol Med Microbiol. 2009 Nov;57(2):165-72. doi: 10.1111/j.1574-695X.2009.00595.x. Epub 2009 Aug 6.
4
A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.叶绿体中表达的植物源性保护性抗原 [PA(dIV)] 疫苗可在小鼠中诱导针对炭疽病的保护性免疫。
Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.
5
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.用新型纳米乳剂重组炭疽保护性抗原疫苗进行黏膜免疫可抵御炭疽芽孢杆菌孢子攻击。
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.
6
S-layer homology motif is an immunogen and confers protection to mouse model against anthrax.S 层同源基序是一种免疫原,可对炭疽病的小鼠模型提供保护。
Mol Immunol. 2012 Feb;50(1-2):18-25. doi: 10.1016/j.molimm.2011.11.007. Epub 2011 Dec 16.
7
Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.用PA63、LF和聚谷氨酸共轭物的混合物进行鼻腔免疫,可诱导针对所有三种抗原的强烈抗体反应。
FEMS Immunol Med Microbiol. 2008 Mar;52(2):169-79. doi: 10.1111/j.1574-695X.2007.00347.x. Epub 2008 Jan 9.
8
Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.DNA疫苗接种后小鼠对炭疽芽孢杆菌STI孢子攻击的保护作用。
Int J Med Microbiol. 2004 Jul;294(1):35-44. doi: 10.1016/j.ijmm.2003.12.002.
9
Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.通过用编码致死因子蛋白的质粒进行基因免疫来抵御炭疽致死毒素攻击。
Infect Immun. 2001 Jul;69(7):4509-15. doi: 10.1128/IAI.69.7.4509-4515.2001.
10
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.基于表达致死毒素成分突变变体的菌株的高效、无毒炭疽芽孢杆菌疫苗。
Vaccine. 2005 Dec 1;23(48-49):5688-97. doi: 10.1016/j.vaccine.2004.11.077. Epub 2005 Feb 5.

引用本文的文献

1
Structure and function of the EA1 surface layer of Bacillus anthracis.炭疽芽胞杆菌 EA1 表面层的结构与功能。
Nat Commun. 2023 Nov 3;14(1):7051. doi: 10.1038/s41467-023-42826-x.
2
S-layer proteins as immune players: Tales from pathogenic and non-pathogenic bacteria.作为免疫参与者的S层蛋白:来自致病和非致病细菌的故事。
Curr Res Microb Sci. 2023 Mar 24;4:100187. doi: 10.1016/j.crmicr.2023.100187. eCollection 2023.
3
S-layers: The Proteinaceous Multifunctional Armors of Gram-Positive Pathogens.S层:革兰氏阳性病原体的蛋白质多功能铠甲
Front Microbiol. 2021 Apr 6;12:663468. doi: 10.3389/fmicb.2021.663468. eCollection 2021.
4
The Cell Envelope: Composition, Physiological Role, and Clinical Relevance.细胞包膜:组成、生理作用及临床意义。
Microorganisms. 2020 Nov 26;8(12):1864. doi: 10.3390/microorganisms8121864.
5
Immunogenicity and Protective Efficacy of a Non-Living Anthrax Vaccine versus a Live Spore Vaccine with Simultaneous Penicillin-G Treatment in Cattle.牛用非活性炭疽疫苗与活芽孢疫苗同时联合青霉素G治疗的免疫原性和保护效力
Vaccines (Basel). 2020 Oct 9;8(4):595. doi: 10.3390/vaccines8040595.
6
Characterization of the UK anthrax vaccine and human immunogenicity.英国炭疽疫苗的特性及人体免疫原性
Hum Vaccin Immunother. 2021 Mar 4;17(3):747-758. doi: 10.1080/21645515.2020.1799668. Epub 2020 Sep 8.
7
Characterization of Spore Proteins Using a Nanoscaffold Vaccine Platform.利用纳米支架疫苗平台对孢子蛋白进行表征。
Front Immunol. 2020 Jun 23;11:1264. doi: 10.3389/fimmu.2020.01264. eCollection 2020.
8
Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.针对炭疽杆菌营养细胞和孢子的 EA752-862 单克隆抗体的功能表征和保护效力评估。
Med Microbiol Immunol. 2020 Apr;209(2):125-137. doi: 10.1007/s00430-019-00650-5. Epub 2019 Dec 6.
9
Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.在野外条件下,重组肽与来自致死性炭疽芽孢杆菌的福尔马林灭活孢子组合对农场山羊的保护作用。
BMC Vet Res. 2017 Jul 12;13(1):220. doi: 10.1186/s12917-017-1140-2.
10
Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.鉴定肽序列作为炭疽疫苗储存期间稳定性的一种衡量指标。
Hum Vaccin Immunother. 2014;10(6):1669-81. doi: 10.4161/hv.28443. Epub 2014 Mar 17.